During the symptomatic stage of ALS pathology, CD8+ T cells infiltrate the CNS and contribute to neurodegeneration, as ablation of CD8+ T cells reduces motor neuron loss (Coque et al., 2019). The gene discussed is CD8A; the disease is amyotrophic lateral sclerosis.